WuXi Biologics (Cayman) Inc (WXXWY)
3.60
-0.13
(-3.49%)
USD |
OTCM |
May 17, 15:57
WuXi Biologics Total Long Term Debt (Quarterly): 302.93M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 302.93M |
| June 30, 2023 | 388.07M |
| December 31, 2022 | 403.37M |
| June 30, 2022 | 429.60M |
| December 31, 2021 | 433.38M |
| June 30, 2021 | 500.31M |
| December 31, 2020 | 398.69M |
| June 30, 2020 | 416.05M |
| Date | Value |
|---|---|
| December 31, 2019 | 271.74M |
| June 30, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 178.16M |
| December 31, 2016 | 156.71M |
| June 30, 2016 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
500.31M
Maximum
Jun 2021
354.42M
Average
401.03M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Wuxi AppTec Co Ltd | 848.04M |
| Sinovac Biotech Ltd | 253.91M |
| CASI Pharmaceuticals Inc | 18.90M |
| Zai Lab Ltd | 48.27M |
| Gracell Biotechnologies Inc (DELISTED) | -- |